Why Is DOXIMITY INC A (DOCS) Stock Up Today?

DOCS stock surged 33.97% to $27.68 on Monday, driven by a sharp intraday gap up and a wave of analyst upgrades. The stock opened at $44.06, more than 113% higher than the prior close, and saw a flurry of price target increases from key firms. Despite mixed Q1 earnings, the rally reflects growing optimism around the company’s AI-driven medical platform and revised forward guidance.

What Happened

Doximity’s stock opened with a massive gap up, reaching $44.06 at the open, and peaked at $68.05 shortly after 7:15 AM ET. The session saw heavy volume of 34.1 million shares, more than nine times the 3-month average. Analysts at Needham and Raymond James raised their price targets to $41 and $38 respectively, reflecting confidence in the company’s AI engagement and platform adoption. The stock closed the session at $27.72, down from its intraday high but still sharply higher than its previous close. The company reported Q1 results below estimates but highlighted strong revenue growth and robust engagement metrics, signaling continued top-line momentum into fiscal 2027.

What The Data Shows

The stock has gained 59.2% over the past eight sessions, rising from $21.63 to $34.43. Over the 52-week period, it has traded between $17.15 and $76.51, suggesting the current price remains within a broader historical range. Insiders have sold a total of $148K in the last 90 days, with the most recent transaction occurring on July 20. Congressional trades include recent sales by Donald J. Trump. Options activity shows a notable call premium of $0 versus a put premium of $625K, with the largest single print at $625K.

What To Watch

Doximity’s forward guidance and continued AI integration will be key to monitoring the stock’s trajectory. Investors should also track the breadth of analyst coverage and any further price target revisions in the coming weeks.